摘要:
The present invention provides compounds represented by Formula I. R0 is selected from hydrogen, halogen, lower alkyl, —SR8, —OR8, —CN, and —NHR8, R1 is halogen, or lower alkyl; R2 is —NHR8; R3 is selected from the group consisting of hydrogen, halogen, —SR8, —OR8, —CN, —C(O)R9, —C(O)OH, —NO2, —NR8R10, lower alkyl, lower alkenyl, lower alkynyl, lower perhaloalkyl, aryl, heteroaryl, alicyclic and heterocyclic, all optionally substituted, and R5 is aryl, heteroaryl, alicyclic, or heterocyclic:
摘要翻译:本发明提供由式I表示的化合物。R 0选自氢,卤素,低级烷基,-SR 8,-OR 8, ,-CN和-NHR 8,R 1是卤素或低级烷基; R 2是-NHR 8; R 3选自氢,卤素,-SR 8,-OR 8,-CN,-C(O) R 9,-C(O)OH,-NO 2,-NR 8 R 10,低级烷基 ,低级烯基,低级炔基,低级全卤代烷基,芳基,杂芳基,脂环族和杂环基,全部被取代,R 5是芳基,杂芳基,脂环族或杂环基:
摘要:
Zearalanol compounds are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various disorders. Methods of synthesis and use of such compounds are also described and claimed.